Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement

NCT01411657 is registered in ClinicalTrials.gov with Jeffrey L Goldberg as lead sponsor.

NCT NCT01411657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01411657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement
Lead sponsor
Jeffrey L Goldberg
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2011
Completion date
October 31, 2014
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic optic neuropathy/optic nerve stroke